Bernard Ravina

Bernard Ravina is an EIR with over 20 years of drug development experience in government, academia, and industry. Most recently he was CMO of Praxis Precision Medicines. Prior to that he served as CMO of Voyager Therapeutics and worked in clinical development at Biogen. Dr. Ravina holds an M.D. from the Johns Hopkins University School of Medicine and a Master’s in Clinical Epidemiology and Biostatistics from the University of Pennsylvania, where he completed training in neurology. After training, Dr. Ravina held positions at NINDS/NIH in neurogenetics and at the University of Rochester School of Medicine where he was Associate Professor of Neurology and Director of the Movement and Inherited Neurological Disorders Unit..